Lumpectomy Market in Europe 2017-2021
出 版 商：Technavio
出版日期：2017/03/13
頁 數：70頁
文件格式：PDF
價 格：
USD 3,500 (Single-User License)
USD 4,500 (Multi-User License)
USD 5,000 (Global-User License)
USD 4,500 (Multi-User License)
USD 5,000 (Global-User License)
ABSTRACT
About Lumpectomy Devices
According to a NHS report of July 2015, eight out of ten women are diagnosed with breast cancer in the UK and survive for minimum five years post diagnosis. Lumpectomy, a type of breast-conserving therapy for treating breast cancer, has emerged in the European market, owing to the presence of innovative technologies. Intraoperative surgical margin, sentinel lymph node biopsy assessment systems, and surgical tools are some of the technical devices used in the treatment of lumpectomy.
Technavio’s analysts forecast the lumpectomy market in Europe to grow at a CAGR of 6.32% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the lumpectomy market in Europe for 2017-2021. To calculate the market size, the report presents the vendor landscape and a corresponding detailed analysis of the top two vendors operating in the market.
The market is divided into the following segments based on geography:
‧ France
‧ Germany
‧ Italy
‧ Spain
‧ UK
Technavio's report, Lumpectomy Market in Europe 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
‧ Dune Medical Devices
‧ iCAD
Other prominent vendors
‧ ClearCut Medical
‧ Hologic
‧ Medtronic
‧ Sanarus
‧ Vector Surgical
‧ ZEISS
Market driver
‧ Increasing adoption of mammography for early breast cancer detection.
‧ For a full, detailed list, view our report
Market challenge
‧ Reluctance to adopt lumpectomy owing to associated high cost.
‧ For a full, detailed list, view our report
Market trend
‧ Transformation of marketing and sales strategies for lumpectomy.
‧ For a full, detailed list, view our report
Key questions answered in this report
‧ What will the market size be in 2021 and what will the growth rate be?
‧ What are the key market trends?
‧ What is driving this market?
‧ What are the challenges to market growth?
‧ Who are the key vendors in this market space?
‧ What are the market opportunities and threats faced by the key vendors?
‧ What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
About Lumpectomy Devices
According to a NHS report of July 2015, eight out of ten women are diagnosed with breast cancer in the UK and survive for minimum five years post diagnosis. Lumpectomy, a type of breast-conserving therapy for treating breast cancer, has emerged in the European market, owing to the presence of innovative technologies. Intraoperative surgical margin, sentinel lymph node biopsy assessment systems, and surgical tools are some of the technical devices used in the treatment of lumpectomy.
Technavio’s analysts forecast the lumpectomy market in Europe to grow at a CAGR of 6.32% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the lumpectomy market in Europe for 2017-2021. To calculate the market size, the report presents the vendor landscape and a corresponding detailed analysis of the top two vendors operating in the market.
The market is divided into the following segments based on geography:
‧ France
‧ Germany
‧ Italy
‧ Spain
‧ UK
Technavio's report, Lumpectomy Market in Europe 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
‧ Dune Medical Devices
‧ iCAD
Other prominent vendors
‧ ClearCut Medical
‧ Hologic
‧ Medtronic
‧ Sanarus
‧ Vector Surgical
‧ ZEISS
Market driver
‧ Increasing adoption of mammography for early breast cancer detection.
‧ For a full, detailed list, view our report
Market challenge
‧ Reluctance to adopt lumpectomy owing to associated high cost.
‧ For a full, detailed list, view our report
Market trend
‧ Transformation of marketing and sales strategies for lumpectomy.
‧ For a full, detailed list, view our report
Key questions answered in this report
‧ What will the market size be in 2021 and what will the growth rate be?
‧ What are the key market trends?
‧ What is driving this market?
‧ What are the challenges to market growth?
‧ Who are the key vendors in this market space?
‧ What are the market opportunities and threats faced by the key vendors?
‧ What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
‧ Market overview
‧ Top-vendor offerings
PART 03: Market research methodology
‧ Research methodology
‧ Economic indicators
PART 04: Introduction
‧ Key market highlights
‧ Breast cancer in Europe
‧ Lumpectomy—treatment of breast cancer
PART 05: Market landscape
‧ Market Overview
‧ Market size and forecast
‧ Five forces analysis
PART 06: Market segmentation by product
‧ Systems
‧ Surgical tools
PART 07: Market segmentation by end-user
‧ Hospitals and integrated breast cancer centers
‧ ASCs
PART 08: Geographical segmentation
‧ Breast cancer screening programs in five European countries
‧ France
‧ Germany
‧ Italy
‧ Spain
‧ UK
‧ Others
PART 09: Market drivers
‧ Government initiatives to increase public awareness of breast cancer
‧ Increasing adoption of mammography for early breast cancer detection
‧ Increasing number of hospital beds to facilitate cancer diagnosis and treatment
PART 10: Impact of drivers
PART 11: Market challenges
‧ Reluctance to adopt lumpectomy owing to associated high cost
‧ Unavailability of government programs for younger women
‧ Poor cosmetic results
PART 12: Impact of drivers and challenges
PART 13: Market trends
‧ Presence of venture capitalists for developing lumpectomy devices
‧ Transformation of marketing and sales strategies for lumpectomy
‧ Emergence of integrated breast cancer treatment centers
PART 14: Vendor landscape
‧ Competitive landscape analysis
‧ Focus on companies
PART 15: Key vendor analysis
‧ Dune Medical Devices
‧ iCAD
‧ Key companies to watch
‧ Other prominent vendors
PART 16: Appendix
‧ List of abbreviations
List of Exhibits
Exhibit 01: Market assumptions to calculate the market size
Exhibit 02: Product offerings
Exhibit 03: Breast cancer: Cancer deaths in Europe (2013)
Exhibit 04: Lumpectomy procedure
Exhibit 05: European countries: Government plans for breast cancer screening programs
Exhibit 06: Products and technologies used in invasive lumpectomy procedures
Exhibit 07: Products under development: Companies and universities
Exhibit 08: Products and technologies used in MI invasive lumpectomy procedures
Exhibit 09: Lumpectomy market in Europe 2016-2021 ($ billions)
Exhibit 10: Five forces analysis
Exhibit 11: Market overview: Systems
Exhibit 12: Unmet needs and focus of companies
Exhibit 13: Market impact analysis: Systems
Exhibit 14: Market overview: Surgical tools
Exhibit 15: Unmet needs and focus on companies
Exhibit 16: Market impact analysis: Surgical tools
Exhibit 17: Lumpectomy market in Europe by end-user 2016
Exhibit 18: Breast cancer screening programs: Five major countries in Europe
Exhibit 19: Estimated number of new breast cancer and lumpectomy cases in France 2016-2021
Exhibit 20: Lumpectomy market in France 2016
Exhibit 21: Market overview: France
Exhibit 22: Lumpectomy market revenue in France 2016-2021 ($ millions)
Exhibit 23: Lumpectomy market by single and re-excision 2016-2021 (%)
Exhibit 24: Cost component of lumpectomy procedure
Exhibit 25: Estimated number of new breast cancer and lumpectomy cases in Germany 2016-2021
Exhibit 26: Lumpectomy market in Germany 2016
Exhibit 27: Market overview: Germany
Exhibit 28: Lumpectomy market revenue in Germany 2016-2021 ($ millions)
Exhibit 29: Lumpectomy market by single and re-excision in Germany (by %)
Exhibit 30: Cost component of lumpectomy procedure
Exhibit 31: Estimated number of new breast cancer and lumpectomy cases in Italy 2016-2021
Exhibit 32: Lumpectomy market in Italy 2016
Exhibit 33: Market overview: Italy
Exhibit 34: Lumpectomy market revenue in Italy 2016-2021 ($ millions)
Exhibit 35: Lumpectomy market by single and re-excision in Italy (%)
Exhibit 36: Cost component of lumpectomy procedure
Exhibit 37: Estimated number of new breast cancer and lumpectomy cases in Spain 2016-2021
Exhibit 38: Lumpectomy market in Spain 2016
Exhibit 39: Market overview: Spain
Exhibit 40: Lumpectomy market revenue in Spain 2016-2021 ($ millions)
Exhibit 41: Lumpectomy market by single and re-excision in Spain (%)
Exhibit 42: Cost component of lumpectomy procedure
Exhibit 43: Estimated number of new breast cancer and lumpectomy cases in UK 2016-2021
Exhibit 44: Lumpectomy market in UK 2016
Exhibit 45: Market overview: UK
Exhibit 46: Lumpectomy market revenue in UK 2016-2021 ($ millions)
Exhibit 47: Cost component of lumpectomy procedure
Exhibit 48: Lumpectomy market in others 2016
Exhibit 49: Lumpectomy market revenue in others 2016-2021 ($ billions)
Exhibit 50: Market overview: Lumpectomy market in Austria
Exhibit 51: Market overview: Lumpectomy market in Belgium
Exhibit 52: Market overview: Lumpectomy market in Czech Republic
Exhibit 53: Market overview: Lumpectomy market in Greece
Exhibit 54: Market overview: Lumpectomy market in Netherlands
Exhibit 55: Market overview: Lumpectomy market in Portugal
Exhibit 56: Market overview: Lumpectomy market in Russia
Exhibit 57: Market overview: Lumpectomy market in Sweden
Exhibit 58: Market overview: Lumpectomy market in Switzerland
Exhibit 59: Awareness programs by EU
Exhibit 60: Percentage of women screened for mammography and survival rate of women with breast cancer 2013 (based on OECD 2015)
Exhibit 61: Number of hospital beds and discharge of cancer patient per 1,000 inhabitants in 2015
Exhibit 62: Impact of drivers
Exhibit 63: Cost component of lumpectomy procedure
Exhibit 64: Post-lumpectomy radiation cost
Exhibit 65: Age-standard incidence of breast cancer in women below and above 40 years of age in 2013
Exhibit 66: Impact of drivers and challenges
Exhibit 67: Market impact analysis: Funding by investors for lumpectomy
Exhibit 68: Marketing and sales strategies of large and small companies
Exhibit 69: Competitive structure analysis of lumpectomy market in Europe 2016
Exhibit 70: Competitive landscape analysis of lumpectomy market in Europe 2016
Exhibit 71: Strategic focus on new players in the lumpectomy market
Exhibit 72: Strategic focus of existing players in the lumpectomy market
Exhibit 73: Dune Medical Devices strength assessment
Exhibit 74: Dune Medical Devices strategy assessment
Exhibit 75: Dune Medical Devices opportunity assessment
Exhibit 76: iCAD strength assessment
Exhibit 77: iCAD strategy assessment
Exhibit 78: iCAD opportunity assessment
Exhibit 79: Key companies to watch
Exhibit 80: Other prominent vendors
PART 01: Executive summary
PART 02: Scope of the report
‧ Market overview
‧ Top-vendor offerings
PART 03: Market research methodology
‧ Research methodology
‧ Economic indicators
PART 04: Introduction
‧ Key market highlights
‧ Breast cancer in Europe
‧ Lumpectomy—treatment of breast cancer
PART 05: Market landscape
‧ Market Overview
‧ Market size and forecast
‧ Five forces analysis
PART 06: Market segmentation by product
‧ Systems
‧ Surgical tools
PART 07: Market segmentation by end-user
‧ Hospitals and integrated breast cancer centers
‧ ASCs
PART 08: Geographical segmentation
‧ Breast cancer screening programs in five European countries
‧ France
‧ Germany
‧ Italy
‧ Spain
‧ UK
‧ Others
PART 09: Market drivers
‧ Government initiatives to increase public awareness of breast cancer
‧ Increasing adoption of mammography for early breast cancer detection
‧ Increasing number of hospital beds to facilitate cancer diagnosis and treatment
PART 10: Impact of drivers
PART 11: Market challenges
‧ Reluctance to adopt lumpectomy owing to associated high cost
‧ Unavailability of government programs for younger women
‧ Poor cosmetic results
PART 12: Impact of drivers and challenges
PART 13: Market trends
‧ Presence of venture capitalists for developing lumpectomy devices
‧ Transformation of marketing and sales strategies for lumpectomy
‧ Emergence of integrated breast cancer treatment centers
PART 14: Vendor landscape
‧ Competitive landscape analysis
‧ Focus on companies
PART 15: Key vendor analysis
‧ Dune Medical Devices
‧ iCAD
‧ Key companies to watch
‧ Other prominent vendors
PART 16: Appendix
‧ List of abbreviations
List of Exhibits
Exhibit 01: Market assumptions to calculate the market size
Exhibit 02: Product offerings
Exhibit 03: Breast cancer: Cancer deaths in Europe (2013)
Exhibit 04: Lumpectomy procedure
Exhibit 05: European countries: Government plans for breast cancer screening programs
Exhibit 06: Products and technologies used in invasive lumpectomy procedures
Exhibit 07: Products under development: Companies and universities
Exhibit 08: Products and technologies used in MI invasive lumpectomy procedures
Exhibit 09: Lumpectomy market in Europe 2016-2021 ($ billions)
Exhibit 10: Five forces analysis
Exhibit 11: Market overview: Systems
Exhibit 12: Unmet needs and focus of companies
Exhibit 13: Market impact analysis: Systems
Exhibit 14: Market overview: Surgical tools
Exhibit 15: Unmet needs and focus on companies
Exhibit 16: Market impact analysis: Surgical tools
Exhibit 17: Lumpectomy market in Europe by end-user 2016
Exhibit 18: Breast cancer screening programs: Five major countries in Europe
Exhibit 19: Estimated number of new breast cancer and lumpectomy cases in France 2016-2021
Exhibit 20: Lumpectomy market in France 2016
Exhibit 21: Market overview: France
Exhibit 22: Lumpectomy market revenue in France 2016-2021 ($ millions)
Exhibit 23: Lumpectomy market by single and re-excision 2016-2021 (%)
Exhibit 24: Cost component of lumpectomy procedure
Exhibit 25: Estimated number of new breast cancer and lumpectomy cases in Germany 2016-2021
Exhibit 26: Lumpectomy market in Germany 2016
Exhibit 27: Market overview: Germany
Exhibit 28: Lumpectomy market revenue in Germany 2016-2021 ($ millions)
Exhibit 29: Lumpectomy market by single and re-excision in Germany (by %)
Exhibit 30: Cost component of lumpectomy procedure
Exhibit 31: Estimated number of new breast cancer and lumpectomy cases in Italy 2016-2021
Exhibit 32: Lumpectomy market in Italy 2016
Exhibit 33: Market overview: Italy
Exhibit 34: Lumpectomy market revenue in Italy 2016-2021 ($ millions)
Exhibit 35: Lumpectomy market by single and re-excision in Italy (%)
Exhibit 36: Cost component of lumpectomy procedure
Exhibit 37: Estimated number of new breast cancer and lumpectomy cases in Spain 2016-2021
Exhibit 38: Lumpectomy market in Spain 2016
Exhibit 39: Market overview: Spain
Exhibit 40: Lumpectomy market revenue in Spain 2016-2021 ($ millions)
Exhibit 41: Lumpectomy market by single and re-excision in Spain (%)
Exhibit 42: Cost component of lumpectomy procedure
Exhibit 43: Estimated number of new breast cancer and lumpectomy cases in UK 2016-2021
Exhibit 44: Lumpectomy market in UK 2016
Exhibit 45: Market overview: UK
Exhibit 46: Lumpectomy market revenue in UK 2016-2021 ($ millions)
Exhibit 47: Cost component of lumpectomy procedure
Exhibit 48: Lumpectomy market in others 2016
Exhibit 49: Lumpectomy market revenue in others 2016-2021 ($ billions)
Exhibit 50: Market overview: Lumpectomy market in Austria
Exhibit 51: Market overview: Lumpectomy market in Belgium
Exhibit 52: Market overview: Lumpectomy market in Czech Republic
Exhibit 53: Market overview: Lumpectomy market in Greece
Exhibit 54: Market overview: Lumpectomy market in Netherlands
Exhibit 55: Market overview: Lumpectomy market in Portugal
Exhibit 56: Market overview: Lumpectomy market in Russia
Exhibit 57: Market overview: Lumpectomy market in Sweden
Exhibit 58: Market overview: Lumpectomy market in Switzerland
Exhibit 59: Awareness programs by EU
Exhibit 60: Percentage of women screened for mammography and survival rate of women with breast cancer 2013 (based on OECD 2015)
Exhibit 61: Number of hospital beds and discharge of cancer patient per 1,000 inhabitants in 2015
Exhibit 62: Impact of drivers
Exhibit 63: Cost component of lumpectomy procedure
Exhibit 64: Post-lumpectomy radiation cost
Exhibit 65: Age-standard incidence of breast cancer in women below and above 40 years of age in 2013
Exhibit 66: Impact of drivers and challenges
Exhibit 67: Market impact analysis: Funding by investors for lumpectomy
Exhibit 68: Marketing and sales strategies of large and small companies
Exhibit 69: Competitive structure analysis of lumpectomy market in Europe 2016
Exhibit 70: Competitive landscape analysis of lumpectomy market in Europe 2016
Exhibit 71: Strategic focus on new players in the lumpectomy market
Exhibit 72: Strategic focus of existing players in the lumpectomy market
Exhibit 73: Dune Medical Devices strength assessment
Exhibit 74: Dune Medical Devices strategy assessment
Exhibit 75: Dune Medical Devices opportunity assessment
Exhibit 76: iCAD strength assessment
Exhibit 77: iCAD strategy assessment
Exhibit 78: iCAD opportunity assessment
Exhibit 79: Key companies to watch
Exhibit 80: Other prominent vendors
